T1	intervention 0 26	Sentinel lymph node biopsy
T3	total-participants 707 710	842
T4	eligibility 711 762	patients with node negative, invasive breast cancer
T5	outcome 1114 1117	SNs
T6	outcome 1437 1484	accurately predicted axillary lymph node status
T7	iv-bin-abs 1488 1490	68
T8	intervention-participants 1494 1496	71
T9	iv-bin-percent 1507 1512	95.8%
T10	outcome 1270 1301	confirmed the SN to be negative
T11	iv-bin-abs 1305 1307	37
T12	intervention-participants 1311 1313	40
T13	iv-bin-abs 1332 1337	three
T14	outcome 1356 1389	positive non-sentinel lymph nodes
T15	iv-bin-abs 1185 1195	Thirty-one
T16	outcome 1211 1222	positive SN
T17	iv-bin-abs 1224 1226	40
T18	outcome 1229 1240	negative SN
T19	iv-bin-abs 1137 1139	71
T20	intervention-participants 1143 1145	75
T21	iv-bin-percent 1177 1182	94.7%
